Cite
HARVARD Citation
Oza, A. et al. (n.d.). Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial. Lancet oncology. 16 (8), pp. 928-936. [Online].